| Jonathan Paul Mannas, MD | |
|
3601 21st St, Lubbock, TX 79410-1229 | |
| (806) 791-0399 | |
| (806) 791-0373 |
| Full Name | Jonathan Paul Mannas |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 15 Years |
| Location | 3601 21st St, Lubbock, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740414895 | NPI | - | NPPES |
| 519360YKT8 | Other | TX | MEDICARE |
| 8GC015 | Other | TX | BCBS TX |
| 221101200 | Other | TX | FIRSTCARE |
| 360501601 | Medicaid | TX | |
| 84977060 | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | Q8746 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Covenant Medical Center | Lubbock, TX | Hospital |
| Lea Regional Medical Center | Hobbs, NM | Hospital |
| Covenant Hospital Plainview | Plainview, TX | Hospital |
| Nor-lea Hospital District | Lovington, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Covenant Medical Group | 6901889393 | 218 |
News Archive
Rapidly acting drugs to treat depression, anxiety, or substance abuse without side effects do not exist. Researchers led by Bryan L. Roth, MD, PhD, the Michael Hooker Distinguished Professor of Pharmacology at the UNC School of Medicine, are trying to change that.
Elsevier (http://www.elsevier.com), the leading global publisher of scientific, technical, and medical information products and services, announced today the acquisition of NurseSquared (http://www.nursesquared.com) , the leading electronic health record (EHR) training product in the market that teaches students how to properly document using a simulated EHR. The NurseSquared training tool allows Elsevier to offer a more complete curriculum solution, including an EHR training tool, to academic customers.
Resistance to therapy is a major problem in the cancer field. Even when a treatment initially works, the tumors often find ways around the therapy.
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
The decision to stop life-support for incapacitated and critically ill patients is, for surrogate decision makers, often fraught with moral and ethical uncertainty, and long-term emotional consequences. But as difficult as these decisions are, more than half of surrogate decision makers prefer to have full authority over the choice than to share or cede that power to physicians, according to a recent study out of the University of Pittsburgh School of Medicine.
› Verified 9 days ago
| Entity Name | Covenant Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376598904 PECOS PAC ID: 6901889393 Enrollment ID: O20040608000563 |
News Archive
Rapidly acting drugs to treat depression, anxiety, or substance abuse without side effects do not exist. Researchers led by Bryan L. Roth, MD, PhD, the Michael Hooker Distinguished Professor of Pharmacology at the UNC School of Medicine, are trying to change that.
Elsevier (http://www.elsevier.com), the leading global publisher of scientific, technical, and medical information products and services, announced today the acquisition of NurseSquared (http://www.nursesquared.com) , the leading electronic health record (EHR) training product in the market that teaches students how to properly document using a simulated EHR. The NurseSquared training tool allows Elsevier to offer a more complete curriculum solution, including an EHR training tool, to academic customers.
Resistance to therapy is a major problem in the cancer field. Even when a treatment initially works, the tumors often find ways around the therapy.
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
The decision to stop life-support for incapacitated and critically ill patients is, for surrogate decision makers, often fraught with moral and ethical uncertainty, and long-term emotional consequences. But as difficult as these decisions are, more than half of surrogate decision makers prefer to have full authority over the choice than to share or cede that power to physicians, according to a recent study out of the University of Pittsburgh School of Medicine.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan Paul Mannas, MD 2215 Nashville Ave, Lubbock, TX 79410-1105 Ph: (806) 725-5844 | Jonathan Paul Mannas, MD 3601 21st St, Lubbock, TX 79410-1229 Ph: (806) 791-0399 |
News Archive
Rapidly acting drugs to treat depression, anxiety, or substance abuse without side effects do not exist. Researchers led by Bryan L. Roth, MD, PhD, the Michael Hooker Distinguished Professor of Pharmacology at the UNC School of Medicine, are trying to change that.
Elsevier (http://www.elsevier.com), the leading global publisher of scientific, technical, and medical information products and services, announced today the acquisition of NurseSquared (http://www.nursesquared.com) , the leading electronic health record (EHR) training product in the market that teaches students how to properly document using a simulated EHR. The NurseSquared training tool allows Elsevier to offer a more complete curriculum solution, including an EHR training tool, to academic customers.
Resistance to therapy is a major problem in the cancer field. Even when a treatment initially works, the tumors often find ways around the therapy.
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
The decision to stop life-support for incapacitated and critically ill patients is, for surrogate decision makers, often fraught with moral and ethical uncertainty, and long-term emotional consequences. But as difficult as these decisions are, more than half of surrogate decision makers prefer to have full authority over the choice than to share or cede that power to physicians, according to a recent study out of the University of Pittsburgh School of Medicine.
› Verified 9 days ago
Dr. Jason Andrew Felton, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3502 9th St Ste 430, Lubbock, TX 79415 Phone: 806-761-0535 Fax: 806-761-0534 | |
Richard E George, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 4703 113th St, Lubbock, TX 79424 Phone: 806-438-4515 | |
Dr. Benedicto Cortes Baronia, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3502 9th St Ste 430, Lubbock, TX 79415 Phone: 806-761-0535 Fax: 806-761-0534 | |
Dr. Frank Castillon Iii, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2424 50th Sreet, Ste 100, Lubbock, TX 79412 Phone: 806-761-0722 Fax: 806-797-1265 | |
Dr. Stephen Luke Grupke, MD, MS Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3601 21st St, Lubbock, TX 79410 Phone: 806-790-0399 | |
Dr. Mohammed Yanallah Alghamdi, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3502 9th St Ste 430, Lubbock, TX 79415 Phone: 806-761-0535 Fax: 806-761-0534 | |
Ross Sedler, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 3601 21st, Lubbock, TX 79410 Phone: 806-797-2222 Fax: 806-792-7287 |